For the first time ever, the United Nations General Assembly will hold a Noncommunicable Disease (NCD) Summit involving Heads of State, in September 2011, to address the threat posed by NCDs to low- and middle-income countries...
Boston Scientific Corporation (NYSE: BSX) announced it has received CE Mark approval for its TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent (DES) technology. This approval includes a specific indication for the treatment of diabetic...